Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

PFE

Pfizer Inc

Jan 13 • 11:58AM ET

26.47

Dollar change -0.25
Percentage change -0.95	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: MRK JNJ ABBV BMY LLY GILD AMGN BIIB REGN VRTX

| Held by: VTI VOO SCHD SPY IVV VTV XLV VYM VHT IWD

Scroll to Statements

Index	S&P 500	P/E	35.58	EPS (ttm)	0.74	Insider Own	0.04%	Shs Outstand	5.67B	Perf Week	-0.47%
Market Cap	149.98B	Forward P/E	9.15	EPS next Y	2.89	Insider Trans	-0.18%	Shs Float	5.66B	Perf Month	3.50%
Income	4.27B	PEG	3.56	EPS next Q	0.47	Inst Own	67.59%	Short Float	1.34%	Perf Quarter	-9.80%
Sales	60.11B	P/S	2.49	EPS this Y	58.63%	Inst Trans	0.19%	Short Ratio	1.76	Perf Half Y	-8.49%
Book/sh	16.29	P/B	1.62	EPS next Y	-0.92%	ROA	1.97%	Short Interest	75.71M	Perf Year	-8.71%
Cash/sh	1.76	P/C	15.07	EPS next 5Y	10.00%	ROE	4.52%	52W Range	24.48 - 31.54	Perf YTD	-0.25%
Dividend Est.	1.67 (6.30%)	P/FCF	18.23	EPS past 5Y	-27.43%	ROI	2.84%	52W High	-16.09%	Beta	0.61
Dividend TTM	1.68 (6.35%)	Quick Ratio	0.73	Sales past 5Y	19.51%	Gross Margin	58.50%	52W Low	8.11%	ATR (14)	0.53
Dividend Ex-Date	Jan 24, 2025	Current Ratio	1.00	EPS Y/Y TTM	-59.54%	Oper. Margin	16.32%	RSI (14)	50.27	Volatility	2.19% 1.89%
Employees	88000	Debt/Eq	0.73	Sales Y/Y TTM	-12.29%	Profit Margin	7.11%	Recom	2.23	Target Price	31.40
Option/Short	Yes / Yes	LT Debt/Eq	0.63	EPS Q/Q	284.91%	Payout	439.41%	Rel Volume	0.67	Prev Close	26.72
Sales Surprise	18.63%	EPS Surprise	72.53%	Sales Q/Q	33.78%	Earnings	Feb 04 BMO	Avg Volume	42.92M	Price	26.47
SMA20	0.34%	SMA50	0.68%	SMA200	-5.15%	Trades		Volume	11,757,863	Change	-0.95%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40
May-11-23	Downgrade	Daiwa Securities	Outperform → Neutral	$38
Mar-06-23	Initiated	Jefferies	Hold	$43
Feb-07-23	Upgrade	Daiwa Securities	Neutral → Outperform	$51
Jan-26-23	Downgrade	UBS	Buy → Neutral	$55 → $47
Jan-17-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$54 → $50
Jan-04-23	Downgrade	BofA Securities	Buy → Neutral	$60
Dec-13-22	Upgrade	Goldman	Neutral → Buy	$47 → $60

Show Previous Ratings

Today 11:57AM	Is Pfizer Inc. (PFE) the Most Reliable Dividend Stock to Buy According to Hedge Funds? (Insider Monkey)
11:25AM	Moderna cuts sales forecast on weaker vaccine demand (Yahoo Finance)
10:57AM	Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts. (Investor's Business Daily)
09:00AM	3 High-Yield Dividend Stocks to Buy in 2025 (Motley Fool)
07:28AM	Pfizers Phase III bladder cancer therapy trial meets primary endpoint (Clinical Trials Arena)
05:10AM	Loading…
05:10AM	Investing $5,000 Just Once in These 3 Ultra-High-Yielding Stocks Could Earn You $320 in Passive Income Every Year (Motley Fool)
Jan-10-25 03:51PM	The CEOs Who Are Tearing Up the Policies Trump Hates (The Wall Street Journal)
01:42PM	Court Reopens Challenge to Pfizer Fellowship Program Amid Diversity Debate (GuruFocus.com)
01:15PM	Pfizer must face lawsuit over diversity fellowship program, US court rules (Reuters)
12:19PM	Pfizer Reveals Encouraging Data From Pivotal Bladder Cancer Trial (Benzinga)
08:30AM	AI, vaccine distrust, & the future of healthcare: Novartis CEO (Yahoo Finance Video)
06:45AM	Pfizers Sasanlimab in Combination with BCG Improves Event-Free Survival in Patients with BCG-Nave, High-Risk Non-Muscle Invasive Bladder Cancer (Business Wire)
06:45AM	Pfizer's Sasanlimab in Combination with BCG Improves Event-Free Survival in Patients with BCG-Naive, High-Risk Non-Muscle Invasive Bladder Cancer (Business Wire)
06:43AM	Pfizers PD-1 drug succeeds; AbbVie writes down $3.5B in Cerevel assets (BioPharma Dive)
Jan-08-25 09:02PM	Lightning Round: Powell Industries has been a 'big, big disappointment', says Jim Cramer (CNBC TV)
05:45PM	Loading…
05:45PM	Pfizer (PFE) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
04:03PM	Moderna stock forfeits gains as first US bird flu death puts vaccine development in focus (Yahoo Finance)
10:23AM	Walmart CEO Doug McMillon meets with Trump ahead of inauguration (Yahoo Finance)
09:57AM	Theres a Shadow Over Biotech Stocks. Why It Isnt All Bad News. (Barrons.com)
09:13AM	Moderna stock seesaws as first US bird flu death puts vaccine development in focus (Yahoo Finance)
09:13AM	Moderna stock on track for 10% weekly gain after US bird flu death (Yahoo Finance)
07:35AM	FDA adds warning to RSV shots from GSK, Pfizer (BioPharma Dive)
05:48AM	Prediction: These Could Be the Best-Performing Value Stocks Through 2030 (Motley Fool)
Jan-07-25 04:12PM	Moderna, BioNTech, Novavax Surge After CDC Reports Two-Week Covid Spike (Investor's Business Daily)
01:34PM	Is Pfizer Stock A Buy After Shares Rally On A Recent Covid Spike? (Investor's Business Daily)
12:12PM	Moderna Stock Jumps Amid Bird Flu Vaccine Hope After First U.S. Death (Barrons.com)
11:26AM	Vaccine Stocks Surge: Moderna Jumps 11% as COVID-19 and Flu Fears Reignite Immunization Demand (GuruFocus.com)
09:40AM	Why Pfizer (PFE) is a Top Value Stock for the Long-Term (Zacks)
09:00AM	Is Trending Stock Pfizer Inc. (PFE) a Buy Now? (Zacks)
05:46AM	Investing $50,000 in Each of These 5 Stocks Could Make You Nearly $17,500 in Passive Income in 2025 (Motley Fool)
10:00AM	Loading…
Jan-06-25 10:00AM	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Business Wire)
09:59AM	Is Pfizer Inc. (NYSE:PFE) the Best January Dividend Stock to Buy? (Insider Monkey)
08:52AM	Pfizer Antiviral Paxlovid's Extended Use Shows Mixed Results for Long COVID Relief: Study (Benzinga)
07:00AM	Healthcare Stocks Are Down and Out. Opportunities Abound. (The Wall Street Journal)
04:42AM	25 Top Dividend Stocks to Buy and Hold in 2025 (Motley Fool)
Jan-05-25 02:07PM	Amazons Prime Video Acquires Melania Trump Film (The Wall Street Journal)
Jan-03-25 05:30PM	Pfizer has increased prices on over 60 drugs in the U.S. as of Jan. 1 (Fortune)
02:18PM	Venture Capitalist Sues Paypal Over Funding Program for Minority Startups (The Wall Street Journal)
07:13AM	Heres Why Pfizer Inc. (PFE) Is Among The Stocks Targeted By Activist Hedge Funds (Insider Monkey)
05:21AM	3 Ultra-High-Yield Dividend Stocks That Are Screaming Buys in 2025 (Motley Fool)
05:06AM	10 Magnificent Stocks That Can Make You Richer in 2025 (Motley Fool)
Jan-02-25 05:45PM	Pfizer (PFE) Advances While Market Declines: Some Information for Investors (Zacks)
11:38AM	Pfizer Joins Forces with Atavistik Bio to Unlock Revolutionary Cancer Treatments (GuruFocus.com)
10:34AM	3 bullish investor picks for 2025: Cisco, Microsoft, and Reddit (Yahoo Finance Video)
09:50AM	Here's Why Pfizer (PFE) is a Strong Momentum Stock (Zacks)
07:30AM	Got $5,000? These 3 Stocks Are Absurdly Cheap Buys Heading Into 2025 (Motley Fool)
07:03AM	Sangamo Therapeutics Stock Plummets 56% After Pfizer Ends Hemophilia Treatment Partnership (Barrons.com)
06:34AM	Pfizer exits Sangamo pact; Roche, Ideaya strike ADC deals (BioPharma Dive)
Jan-01-25 12:50PM	Jim Cramer's Take on Pfizer Inc. (PFE): Bold Predictions for the Future (Insider Monkey)
03:30AM	Drug-Trial Results Could Shake Up Pharma Stocks in 2025. Watch Eli Lilly, Pfizer, and More. (Barrons.com)
Dec-31-24 11:52AM	Top Stock Movers Now: Moderna, Verisign, Dave, and More (Investopedia)
11:18AM	Pfizer Exit Sends Sangamo Plummeting 50%, Casting Doubt on Hemophilia Gene Therapy's Future (GuruFocus.com)
10:34AM	Sangamo Therapeutics Stock Crashes as Pfizer Ends Hemophilia Drug Pact (Investopedia)
10:23AM	SGMO Pre-Market Shares Drop 40% Over Pfizer (PFE) Deal Collapse (Insider Monkey)
09:56AM	Sangamo stock plummets 50% after Pfizer ends gene therapy deal (Yahoo Finance Video)
09:55AM	Sangamo Plunges After Pfizer Ends Pact for Hemophilia Drug (Bloomberg)
09:14AM	Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy Pact (Benzinga)
08:30AM	Sangamos stock sinks 50% as Pfizer halts haemophilia A gene therapy partnership (Pharmaceutical Technology)
08:30AM	NIH settlement manageable headwind for BioNTech, Pfizer, says Morgan Stanley (TipRanks)
07:30AM	3 Reasons to Buy Pfizer Stock Like There's No Tomorrow (Motley Fool)
07:05AM	Drugmakers to raise US prices on over 250 medicines starting Jan. 1 (Reuters)
06:38AM	Sangamo stock crashes 50% after Pfizer terminates HemoA gene therapy deal (Investing.com)
Dec-30-24 05:26PM	Is Pfizer Inc. (PFE) the Best Pharma Dividend Stock to Buy In 2024? (Insider Monkey)
03:32PM	5 Value Stocks That Could Get a Bump From Activist Investors (Barrons.com)
05:30AM	Drug Middlemen Spared by Trump and Musk, for Now (The Wall Street Journal)
05:06AM	5 Unbeatable Stocks I'm Eager to Buy in 2025 (Motley Fool)
04:04AM	My 5 Favorite Ultra-High-Yield Dividend Stocks to Buy for 2025 (Motley Fool)
Dec-29-24 05:15AM	360 Stocks in the S&P 500 Underperformed the Benchmark's 2024 Gain of 24%. Here's 2 High-Yielding S&P 500 Stocks to Buy in 2025, According to Wall Street. (Motley Fool)
04:15AM	Prediction: This $43 Billion Bet Will Help Pfizer Stock Take Off in 2025. (Motley Fool)
Dec-28-24 09:00PM	Corporate America Drew Back From DEI. The Upheaval Isnt Over. (The Wall Street Journal)
09:40AM	BioNTech to pay $467M in settlement agreement with University of Pennsylvania (TipRanks)
09:35AM	BioNTech to pay $791.5M in settlement agreement with the NIH (TipRanks)
Dec-27-24 07:53AM	BioNTech enters settlement with US agency, UPenn over COVID vaccine royalties (Reuters)
Dec-26-24 05:45PM	Pfizer (PFE) Suffers a Larger Drop Than the General Market: Key Insights (Zacks)
Dec-25-24 10:15AM	4 Dividend Stocks to Double Up on Right Now (Motley Fool)
09:17AM	Is Pfizer Inc. (PFE) the Best Dividend Stock to Buy Under $50? (Insider Monkey)
08:45AM	Better Income Stock: Pfizer or Altria Group? (Motley Fool)
06:30AM	Novo Nordisk is 'losing its pep' in GLP-1 race: BMO analyst (Yahoo Finance Video)
Dec-24-24 09:00PM	The Big Companies Funding Trumps Inauguration Despite Denouncing Jan. 6 (The Wall Street Journal)
12:20PM	3 biggest catalysts expected for healthcare in 2025 (Yahoo Finance Video)
Dec-23-24 09:40AM	Should Value Investors Buy Pfizer (PFE) Stock? (Zacks)
09:00AM	Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know (Zacks)
06:20AM	Pfizers colorectal cancer combo therapy gains accelerated approval from FDA (Pharmaceutical Technology)
05:50AM	Stocking Stuffers for Income Investors: 3 Ultra-High-Yield Dividend Stocks to Buy Before the End of 2024 (Motley Fool)
Dec-22-24 04:25PM	Stuart Therapeutics Announces the Appointment of Two New Board Members (PR Newswire)
11:13AM	Why Pfizer Inc. (PFE) Is One of the Best Stocks to Buy and Hold for 3 Years? (Insider Monkey)
07:00AM	Pfizer Just Reassured Investors, but Is the Stock a Buy? (Motley Fool)
06:50AM	2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off (Motley Fool)
Dec-21-24 09:41AM	Pfizer Inc. (PFE) Is Among the Best Dividend Leaders to Buy According to Wall Street Analysts (Insider Monkey)
05:06AM	The Stock Market Is Historically Pricey: Here's How I'm Positioning My Portfolio for 2025 (Motley Fool)
04:05AM	My Top 10 Stocks to Buy for 2025 (Motley Fool)
Dec-20-24 07:44PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
02:48PM	Novo Nordisk Shares Plunge After New Obesity Shot Disappoints (The Wall Street Journal)
02:03PM	U.S. FDA Approves Pfizers BRAFTOVI Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer (Business Wire)
10:31AM	Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf? (Investor's Business Daily)
07:19AM	Is Pfizer (PFE) a Cheap NYSE Stock to Invest in Now? (Insider Monkey)
Dec-19-24 05:45PM	Why Pfizer (PFE) Dipped More Than Broader Market Today (Zacks)
10:00AM	Pfizer Invites Public to View and Listen to Webcast of February 4 Conference Call with Analysts (Business Wire)
06:07AM	Pfizer Could Soar to $36 Per Share, According to a Wall Street Analyst. Is It a Buy at Around $26? (Motley Fool)
06:00AM	Roam For the Holidays: Grindr Offers Free Access to Their Popular Travel Feature (Business Wire)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Gottlieb Scott	Director	Oct 30 '24	Buy	28.24	1,000	28,240	10,000	Oct 31 04:06 PM
DAMICO JENNIFER B.	SVP & Controller	Aug 13 '24	Sale	28.66	5,154	147,714	8,582	Aug 14 03:47 PM
McDermott Michael	Executive Vice President	Feb 23 '24	Option Exercise	27.34	12,412	339,344	95,408	Feb 27 01:47 PM
SUSMAN SALLY	Executive Vice President	Feb 23 '24	Option Exercise	27.34	63,837	1,745,304	218,148	Feb 27 01:46 PM
SAHNI PAYAL	Executive Vice President	Feb 23 '24	Option Exercise	27.34	11,527	315,148	34,604	Feb 27 01:46 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 23 '24	Option Exercise	27.34	95,755	2,617,942	230,920	Feb 27 01:46 PM
JOHNSON RADY A	Executive Vice President	Feb 23 '24	Option Exercise	27.34	29,436	804,780	123,073	Feb 27 01:46 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 23 '24	Option Exercise	27.34	9,752	266,620	19,228	Feb 27 01:46 PM
BOURLA ALBERT	Chairman & CEO	Feb 23 '24	Option Exercise	27.34	127,674	3,490,607	439,748	Feb 27 01:46 PM
BOSHOFF CHRISTOFFEL	Executive Vice President	Feb 23 '24	Option Exercise	27.34	9,752	266,620	148,703	Feb 27 01:44 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PFE

Pfizer Inc

Upgrade your FINVIZ experience